Skip to main content

Table 1 Percentage of cells expressing CD34 and/or CD133 in haematopoietic stem cell clinical transplant sources and normal blood.

From: Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources

Sources

BM

CB

mPBP

nPB

total leucocytes/ml (106)

1.63 (0.3)

n = 10

1.54 (0.4)

n = 21

1.41 (0.26)

n = 27

1.17 (0.41)

n = 16

CD34+ (% of wbc)

0.71 (0.1)

n = 10

0.42 (0.04)

n = 21

1.46 (0.36)

n = 27

0.09 (0.02)

n = 16

CD133+ (% of wbc)

0.46 (0.07)

n = 8

0.4 (0.05)

n = 7

1.04 (0.2)

n = 7

0.07 (0.01)

n = 16

CD133+ (% of CD34+)

13 (5.65)

n = 8

53 (6.14)

n = 7

79.76 (5.5)

n = 7

11 (3.96)

n = 16

  1. Percentages of cells expressing CD34 and/or CD133 alone or together were compared between the various sources tested. Normal (non-mobilised) peripheral blood (nPB), bone marrow (BM), umbilical cord blood (CB) and G-CSF-mobilised peripheral blood samples (mPBP). Results are expressed as the mean (standard error); n = number of samples tested. White blood cells (wbc) are all leucocytes in the samples analysed, including mononuclear and granulocytic populations.